An initial triptan prescription was linked with ischemic stroke and myocardial infarction for people with a high-risk cardiovascular profile, a case-crossover study in Denmark found. Among more than ...

Four triptans are more effective for acute migraine than newer, more expensive medications for this headache type, new research suggested. International guidelines generally endorse NSAIDs as the ...

Prenatal exposure to triptans, alone or with other migraine medications, was not associated with a significantly increased risk for neurodevelopmental disorders (NDDs) in children born to mothers with ...

Triptan use may be associated with a low increased risk for cerebral events, such as stroke, among older adults. Older adults prescribed second-generation serotonin 5HT1B/1D-receptor agonists ...

Please provide your email address to receive an email when new articles are posted on . A retrospective claims analysis included more than 184,000 individuals with migraine who used at least one ...

Please provide your email address to receive an email when new articles are posted on . A survey of 211 adults with migraine examined their experience with triptans or gepants. Ubrogepant was superior ...

Migraines are characterized by moderate to severe headache attacks and are commonly considered polygenic disorders. Typically, migraines are treated with triptans like serotonin receptor agonists; ...

The risk of autism disorders was slightly, but not significantly, elevated with both triptan late discontinuation trajectories. (HealthDay News) — Children prenatally exposed to different triptan ...

Note: As of November 2025, Eli Lilly discontinued manufacturing Reyvow. The decision was likely due to declining sales and increased market competition rather than concerns about its safety or ...